Journal profile · Medicine-General Medicine
Scripta Medica
ISSN 2490-3329 · eISSN 2303-7954 · Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine · Bosnia and Herzegovina
Scripta Medica: diamond open access (no APC); no APC; review about 4 weeks (community reports); 120 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Scripta Medica is published by Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine. By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, Diabetes, Cardiovascular Risks, and Lipoproteins and Anesthesia and Pain Management, together about 17% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Scripta Medica publishes articles from all areas of medicine: preventive, clinical and experimental. It includes original articles, reviews, special articles, current topics, history of medicine articles and case reports. The journal also publishes editorials, based on one of the articles appearing in the same issue or on some other important topics. Since January, 2019, it has been published exclusively in English.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief Miloš P. StojiljkovićPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine6.6%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine5.2%
- Anesthesia and Pain ManagementMedicine5.2%
- Medicinal Plant ResearchAgricultural and Biological Sciences5.2%
- Mesenchymal stem cell researchMedicine4.6%
- Bone fractures and treatmentsMedicine4.6%
- Diabetes Treatment and ManagementMedicine4.3%
- Anesthesia and Sedative AgentsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EBSCO, Dimensions, CrossrefPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.24LetPub ·
- h-index
- 9OpenAlex ·
- i10-index
- 8OpenAlex ·
- 2-year mean citedness
- 0.53OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 852 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 80 | 80 | 117 |
| 2025 | 120 | 120 | 169 |
| 2024 | 90 | 90 | 103 |
| 2023 | 60 | 60 | 64 |
| 2022 | 47 | 47 | 77 |
| 2021 | 54 | 54 | 68 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 4 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright
Published exclusively in English since January 2019 Model summary
Since January, 2019, it has been published exclusively in English.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
- Country or region
- Bosnia and Herzegovina
- Language
- English, Serbian
- ISSN
- 2490-3329
- Electronic ISSN
- 2303-7954
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Scripta Medica
How long does peer review take at Scripta Medica?
Authors report an average review time of about 4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Scripta Medica?
According to LetPub and DOAJ records, Scripta Medica is indexed in Scopus and DOAJ.
Is Scripta Medica open access, and what is the APC?
Scripta Medica is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .